Organogenesis Inc

Canton, MA, United States

Organogenesis Inc

Canton, MA, United States

Time filter

Source Type

Global Bio-implants market is accounted for $60.3 billion in 2015 and is expected to reach $129.1 billion by 2022 growing at a CAGR of 11.4% from 2015 to 2022. The factors driving the bio-implants market include rising elderly population, increasing chronic diseases, Non-surgical bio-implants, and awareness about cosmetic implants. However, factors such as high cost of implants, reimbursement issues and biocompatibility are likely to hinder the market growth. The technologies such as 3D printing and nanotechnology, used in manufacturing of bio-implants would further boost the market during the forecast period. The orthopedic implants are expected to witness the high growth during the forecast period. The implantable cardioverter defibrillators (ICDs) are expected to dominate the cardiovascular implants market. North America is estimated to be the largest market followed by Europe owing to sophisticated healthcare infrastructure. Whereas Asia pacific is expected to be the fastest growing region during the forecast period due to rising disposable income and increased access to healthcare services. Some of the key players in global Bio-implants market are Aap Implantate Ag, Abbot Laboratories, Bausch & Lomb Incorporated, Biomet Inc, Biotronik Se & Co. Kg, Boston Scientific Corporation, Cr Bard Inc, Crook Group Inc, Edwards Lifesciences Corporation, Endo Health Solutions Inc, GE Healthcare, Integral Lifesciences Holdings Corporation, Integrated Orbital Implants, Medtronic Inc, Mimedx Group Inc, NuVasive, Inc., Orthofix International N.V., Organogenesis, Inc, Philips Corporation, Johnson & Johnson, Lifenet Health Inc, LifeCell Corporation, Smith & Nephew Plc, Sorin S.P.A., St. Jude Medical Inc, Stryker Corporation, Seikagaku Corporation, Toshiba Corporation, Wl Gore & Associates Inc, Wright Medical Group Incorporated and Zimmer Holdings. Applications Covered: • Cardiovascular implants o Stents o Pacing Devices o Heart Valves o Catheters o Wireless Sensors o Guidewires o Vascular Grafts • Dental and Prosthetic Implants o Root form dental implants o Plate form dental implants • Spinal Bio implants o Cervical Implants o Thoracolumber implants o Machined Allograft Spacers o Motion Preservation implants o Implantable spinal stimulators o Interverteberal spacers • Orthopedic implants o Joint Replacement Bio implants o Trauma Implants o Sport Medicines o Fracture Fixation Devices o Wound Healing • Ophthalmology implants o Intraocular Implants o Glaucoma Implants • Neurostimulators Implants o Deep Brain Stimulators o Spinal Cord Stimulators o Sacral Nerve Stimulators o Vagus Nerve Stimulators o Other Neurostimulation • Other Application o Cosmetic Implants o Tissue Engineering o Drug Implants o Gastroenterological Implants o Gynecological Devices o Otolaryngeal Implants o Urological Implants o Skin & Wound Care Implant What our report offers: - Market share assessments for the regional and country level segments - Market share analysis of the top industry players - Strategic recommendations for the new entrants - Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancements For more information or any query mail at sales@wiseguyreports.com About Us Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. For more information, please visit https://www.wiseguyreports.com/sample-request/959996-bio-implants-global-market-outlook-2016-2022


Receive press releases from IQ4I Research & Consultancy Pvt. Ltd.: By Email IQ4I Research & Consultancy Published a New Report on “Soft Tissue Repair Global Market – Forecast To 2023” Soft tissue consists of body tissues that are not hardened or calcified, damage to these soft tissues can be caused either due to sudden trauma or due to overuse of a particular part of the body. Projected rise in aged population, sports injuries and increased number of medical procedures are the factors driving the market growth. Boston, MA, April 26, 2017 --( Ageing is associated with a decline in muscle mass, strength, number of muscle fibres, changes in muscle contraction and slowing of nerve fibers that activate muscle making them prone to soft tissue injuries. Patients who experience extended immobility, as in the case of obese population, and ones who are at risk for developing chronic wounds or tissue damage, will increase the number of potential patients and thereby increase the number of medical procedures to repair the tissue damages. With substantial reduction in communicable diseases and advancements that are helping in preventing communicable diseases, the world is witnessing a shift towards lifestyle diseases such as cardiovascular diseases and injuries due to recreational sports activities. There has been an explosion in cardiovascular diseases (CVDs) that has reached alarming proportions. Along with these factors, increase in healthcare expenditure and growing emerging markets across the globe is driving the soft tissue repair market. The soft tissue global market is segmented into products, surgery, applications and geography. The products market is further divided into meshes/tissue patches, fixation devices, cardiac repair devices and others. The cardiac repair devices segment accounted largest share, due to technological advancements, increasing awareness, etc. Based on the surgery, the soft tissue repair global market is segmented into open surgery and minimally invasive surgery. Although, open surgery is the traditional form of most surgeries, minimally invasive surgeries are taking over the market in the case of soft tissue repair. Minimally invasive surgery thus accounts for the largest share in this segment. Soft tissue repair global market is classified by application into hernia repair, dental reconstruction, vaginal sling procedures, skin repair, breast reconstruction, orthopedic, cardiac repair, and others. Cardiac repair segment accounted for the largest share, as aged population who are prone to cardiovascular diseases such as cardiac valve stenosis, aneurysm and other cardiac related problems are expected to rise. Skin repair is the fastest growing segment due to increased awareness especially in cases such as diabetic foot ulcers and treatment options. The soft tissue repair global market based on geography is divided into North America, Europe, Asia-Pacific and Rest of the world. North America region commanded the largest revenue market share. However, Asia- Pacific region is expected to grow at the highest due to rising awareness, higher economic growth, large patient pool and rising aged population. The soft tissue repair market is consolidated because the majority of the soft tissue repair market is occupied by players such as Edwards Lifesciences, Abbott Laboratories, Arthrex Inc, Medtronic PLC, and Allergan (Lifecell). Major players in soft tissue repair market include Edwards Lifesciences (U.S.), Medtronic PLC (Ireland), Abbott Laboratories (U.S.), Arthrex Inc (U.S.), Johnson & Johnson (U.S.), C.R. Bard Inc, (U.S.), Allergan (Lifecell) (U.S.), Smith & Nephew (U.K.), Integra Lifesciences (U.S.), Livanova (U.K.), Zimmer Biomet (U.S.), Organogenesis (U.S.), etc. Some of the other companies operating in soft tissue repair global market include, Abiss (Switzerland), Admedus (Australia), Advanced Medical Solutions Group PLC (U.K.), Angiologica BM Srl (Italy), Aroa (New Zealand), Aspide Medical (France), B.Braun (Germany), Braile bio medica (Brazil), Betatech Medical (Turkey), Changzhou DAHUA Corp., Ltd (China), Coloplast (Denmark), Inion Oy (Finland), Kerecis (Iceland), Lotus Surgical Pvt Ltd (India), Novus Scientific (Singapore), Occlutech (Sweden), S & G Biotech, Inc. (South Korea), Strait Access Technologies Pty Ltd (South Africa), Valcare Medical (Israel), Medtentia International Ltd Oy (Finland), etc. Boston, MA, April 26, 2017 --( PR.com )-- Soft tissues are body tissues that are not hardened or calcified, this includes tendon, muscle, skin, fat, and fascia. They typically connect, support, or surround bone and internal organs. Injury to soft tissue can be caused either due to sudden trauma or due to overuse of a particular part of the body. The soft tissue repair treatment is dependent on the type of injury and severity. Minor injuries are recovered on their own or with the use of mild treatment methods such as RICE that is rest, ice, compression and elevation. While, other severe injuries or conditions such as hernia, valve stenosis, third degree burns, ligament tears, etc., may require surgical repairs. As estimated by IQ4I Research, the soft tissue repair global market is expected to grow at CAGR of a high end single digit to reach $21,319.7 million by 2023.Ageing is associated with a decline in muscle mass, strength, number of muscle fibres, changes in muscle contraction and slowing of nerve fibers that activate muscle making them prone to soft tissue injuries. Patients who experience extended immobility, as in the case of obese population, and ones who are at risk for developing chronic wounds or tissue damage, will increase the number of potential patients and thereby increase the number of medical procedures to repair the tissue damages. With substantial reduction in communicable diseases and advancements that are helping in preventing communicable diseases, the world is witnessing a shift towards lifestyle diseases such as cardiovascular diseases and injuries due to recreational sports activities. There has been an explosion in cardiovascular diseases (CVDs) that has reached alarming proportions. Along with these factors, increase in healthcare expenditure and growing emerging markets across the globe is driving the soft tissue repair market.The soft tissue global market is segmented into products, surgery, applications and geography. The products market is further divided into meshes/tissue patches, fixation devices, cardiac repair devices and others. The cardiac repair devices segment accounted largest share, due to technological advancements, increasing awareness, etc.Based on the surgery, the soft tissue repair global market is segmented into open surgery and minimally invasive surgery. Although, open surgery is the traditional form of most surgeries, minimally invasive surgeries are taking over the market in the case of soft tissue repair. Minimally invasive surgery thus accounts for the largest share in this segment.Soft tissue repair global market is classified by application into hernia repair, dental reconstruction, vaginal sling procedures, skin repair, breast reconstruction, orthopedic, cardiac repair, and others. Cardiac repair segment accounted for the largest share, as aged population who are prone to cardiovascular diseases such as cardiac valve stenosis, aneurysm and other cardiac related problems are expected to rise. Skin repair is the fastest growing segment due to increased awareness especially in cases such as diabetic foot ulcers and treatment options.The soft tissue repair global market based on geography is divided into North America, Europe, Asia-Pacific and Rest of the world. North America region commanded the largest revenue market share. However, Asia- Pacific region is expected to grow at the highest due to rising awareness, higher economic growth, large patient pool and rising aged population.The soft tissue repair market is consolidated because the majority of the soft tissue repair market is occupied by players such as Edwards Lifesciences, Abbott Laboratories, Arthrex Inc, Medtronic PLC, and Allergan (Lifecell).Major players in soft tissue repair market include Edwards Lifesciences (U.S.), Medtronic PLC (Ireland), Abbott Laboratories (U.S.), Arthrex Inc (U.S.), Johnson & Johnson (U.S.), C.R. Bard Inc, (U.S.), Allergan (Lifecell) (U.S.), Smith & Nephew (U.K.), Integra Lifesciences (U.S.), Livanova (U.K.), Zimmer Biomet (U.S.), Organogenesis (U.S.), etc.Some of the other companies operating in soft tissue repair global market include, Abiss (Switzerland), Admedus (Australia), Advanced Medical Solutions Group PLC (U.K.), Angiologica BM Srl (Italy), Aroa (New Zealand), Aspide Medical (France), B.Braun (Germany), Braile bio medica (Brazil), Betatech Medical (Turkey), Changzhou DAHUA Corp., Ltd (China), Coloplast (Denmark), Inion Oy (Finland), Kerecis (Iceland), Lotus Surgical Pvt Ltd (India), Novus Scientific (Singapore), Occlutech (Sweden), S & G Biotech, Inc. (South Korea), Strait Access Technologies Pty Ltd (South Africa), Valcare Medical (Israel), Medtentia International Ltd Oy (Finland), etc. Click here to view the list of recent Press Releases from IQ4I Research & Consultancy Pvt. Ltd.


News Article | April 18, 2017
Site: marketersmedia.com

Tissue Engineering is a process involving in-vitro development of tissues or organs. It is done to replace or support the function of defective or injured body part. Tissue engineering involves the application of biology and engineering for innovation of tissue substitutes that can maintain, restore and improve the function of ruptured human tissue. Products developed by this procedure are efficient and durable. Tissue engineering is gaining its popularity in various areas such as burn treatment or wound care, neurology products, orthopedics, urological products and others. On the basis of type of material used, tissue engineering and regeneration market can be segmented into synthetic, genetically modified and biological materials. For more information or any query mail at sales@wiseguyreports.com This report focuses on the Tissue Engineering in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers Allergan Integra Lifesciences C. R. Bard Zimmer Biomet Organogenesis Osiris Therapeutics Cryolife ACell Biocomposites DSM Episkin J-TEC Athersys Biotime B. Braun International Stem Cell Bio Tissue Technologies Market Segment by Regions, regional analysis covers North America (USA, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Columbia etc.) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Market Segment by Applications, can be divided into Orthopedics, Musculoskeletal & Spine Neurology Cardiology & Vascular Skin & Integumentary Others There are 15 Chapters to deeply display the global Tissue Engineering market. Chapter 2, to analyze the top manufacturers of Tissue Engineering, with sales, revenue, and price of Tissue Engineering, in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017; 2 Manufacturers Profiles 2.1 Allergan 2.1.1 Business Overview 2.1.2 Tissue Engineering Type and Applications 2.1.2.1 Type 1 2.1.2.2 Type 2 2.1.3 Allergan Tissue Engineering Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.2 Integra Lifesciences 2.2.1 Business Overview 2.2.2 Tissue Engineering Type and Applications 2.2.2.1 Type 1 2.2.2.2 Type 2 2.2.3 Integra Lifesciences Tissue Engineering Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.3 C. R. Bard 2.3.1 Business Overview 2.3.2 Tissue Engineering Type and Applications 2.3.2.1 Type 1 2.3.2.2 Type 2 2.3.3 C. R. Bard Tissue Engineering Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.4 Zimmer Biomet 2.4.1 Business Overview 2.4.2 Tissue Engineering Type and Applications 2.4.2.1 Type 1 2.4.2.2 Type 2 2.4.3 Zimmer Biomet Tissue Engineering Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.5 Organogenesis 2.5.1 Business Overview 2.5.2 Tissue Engineering Type and Applications 2.5.2.1 Type 1 2.5.2.2 Type 2 2.5.3 Organogenesis Tissue Engineering Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.6 Osiris Therapeutics 2.6.1 Business Overview 2.6.2 Tissue Engineering Type and Applications 2.6.2.1 Type 1 2.6.2.2 Type 2 2.6.3 Osiris Therapeutics Tissue Engineering Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.7 Cryolife 2.7.1 Business Overview 2.7.2 Tissue Engineering Type and Applications 2.7.2.1 Type 1 2.7.2.2 Type 2 2.7.3 Cryolife Tissue Engineering Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.8 ACell 2.8.1 Business Overview 2.8.2 Tissue Engineering Type and Applications 2.8.2.1 Type 1 2.8.2.2 Type 2 2.8.3 ACell Tissue Engineering Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.9 Biocomposites 2.9.1 Business Overview 2.9.2 Tissue Engineering Type and Applications 2.9.2.1 Type 1 2.9.2.2 Type 2 2.9.3 Biocomposites Tissue Engineering Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.10 DSM 2.10.1 Business Overview 2.10.2 Tissue Engineering Type and Applications 2.10.2.1 Type 1 2.10.2.2 Type 2 2.10.3 DSM Tissue Engineering Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.11 Episkin 2.11.1 Business Overview 2.11.2 Tissue Engineering Type and Applications 2.11.2.1 Type 1 2.11.2.2 Type 2 2.11.3 Episkin Tissue Engineering Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.12 J-TEC 2.12.1 Business Overview 2.12.2 Tissue Engineering Type and Applications 2.12.2.1 Type 1 2.12.2.2 Type 2 2.12.3 J-TEC Tissue Engineering Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.13 Athersys 2.13.1 Business Overview 2.13.2 Tissue Engineering Type and Applications 2.13.2.1 Type 1 2.13.2.2 Type 2 2.13.3 Athersys Tissue Engineering Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.14 Biotime 2.14.1 Business Overview 2.14.2 Tissue Engineering Type and Applications 2.14.2.1 Type 1 2.14.2.2 Type 2 2.14.3 Biotime Tissue Engineering Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.15 B. Braun 2.15.1 Business Overview 2.15.2 Tissue Engineering Type and Applications 2.15.2.1 Type 1 2.15.2.2 Type 2 2.15.3 B. Braun Tissue Engineering Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.16 International Stem Cell 2.16.1 Business Overview 2.16.2 Tissue Engineering Type and Applications 2.16.2.1 Type 1 2.16.2.2 Type 2 2.16.3 International Stem Cell Tissue Engineering Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.17 Bio Tissue Technologies 2.17.1 Business Overview 2.17.2 Tissue Engineering Type and Applications 2.17.2.1 Type 1 2.17.2.2 Type 2 2.17.3 Bio Tissue Technologies Tissue Engineering Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 3 Global Tissue Engineering Market Competition, by Manufacturer 3.1 Global Tissue Engineering Sales and Market Share by Manufacturer 3.2 Global Tissue Engineering Revenue and Market Share by Manufacturer 3.3 Market Concentration Rate 3.3.1 Top 3 Tissue Engineering Manufacturer Market Share 3.3.2 Top 6 Tissue Engineering Manufacturer Market Share 3.4 Market Competition Trend For more information or any query mail at sales@wiseguyreports.com ABOUT US: Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of rmaket research reports under these categories and sub-categories. For more information, please visit https://www.wiseguyreports.com


News Article | May 5, 2017
Site: marketersmedia.com

— Market Research Future has a half cooked research report (HCRR) on global Tissue Engineering market which is expected to reach USD 12.6 billion from USD 5.2 billion from 2016 to 2022. Test the market data and market information presented in more than 50 market data tables and figures spread over 80 pages of the project report. Go through the in-depth table of content (TOC) & market synopsis on “Tissue Engineering Market Research Report- Global Forecast to 2022”. Market Highlights: It has been noted that global Tissue Engineering market is growing at rapid pace and is expected to grow tremendously at the CAGR of 22.2%. Globally there is huge demand for Tissue Engineering in various regions. Factors that influence the Tissue Engineering market are increasing technology advancement in healthcare which gives desired results, research area that aims at regenerative alternatives to harvested tissues for transplantation. Moreover increasing development in biological substitutes is influencing the global market for tissue engineering. Tissue engineering is a stimulating research area that aims at regenerative alternatives to collected tissues for transplantation. Biomaterials play a vital role as scaffolds to provide three-dimensional 3D templates and synthetic extracellular-matrix environments for tissue regeneration. It is often beneficial for the scaffolds to mimic certain advantageous characteristics of the natural extracellular matrix, or developmental or would healing programs. Some of the Major players of this market are those that holds the largest market share: • Sanofi (France) • BioMimetic Therapeutics (United States) • StemCellsInc (United States) • Zimmer Biomet (Indiana) • Medtronic (United States) • LifeCell Kinetic Concepts (United States) Other prominent vendors in the market are: • Cook Biotech (United States) • Arteriocyte (United States) • Acelity, Organogenesis (United States) • Athersys (United States) • RTI surgical (United States) • Integra LifeSciences (United States) • Advanced Cell Technology (United States) • CryoLife, (United States) Segmentation: Global Tissue Engineering market has been segmented on the basis of material which includes biomimetic materials synthesis, nano-fibrous materials, composite materials, nano-composite materials and others. Nano-fibrous materials has the largest market share in global Tissue Engineering by material and will be constant in future starting from 2016 lasting till 2022. The main reason for the growth of nano-fibrous material is many extracellular proteins have a fibrous structure with diameters on the nano-meter or sub-micrometer scales. Furthermore on the basis of end-user the market is segmented into Cord Blood & Cell Banking, Cancer, GI & Gynecology, Dental, Skin/Integumentary, Urology, Orthopedics, musculoskeletal and spine, Neurology and Cardiology & Vascular. Orthopedics contribute maximum to the growth of global Tissue Engineering by application due to increased incidence of sports-related injuries, musculoskeletal syndromes have become one of the major health concerns all around the globe. Moreover tissue engineering uses principles of engineering, biology, and chemistry, it provides a more operative approach to the treatment the musculoskeletal disorders than traditional methods. Brief TOC for Tissue Engineering Market: 1 Introduction 1.1 Definition 1.2 Scope of Study 1.3 Research Objective 1.4 Assumptions & Limitations 1.5 Market Structure 2 Research Methodology 2.1 Research Process 2.2 Primary Research 2.3 Secondary Research 3 Market Dynamics 3.1 Drivers 3.2 Restraints 3.3 Opportunities 3.4 Challenges 3.5 Macroeconomic Indicators 4 Market Factor Analysis 4.1 Porter’s five forces model 4.1.1 Bargaining Power of suppliers 4.1.2 Bargaining Power of Customer 4.1.3 Intensity of Competitor’s 4.1.4 Threat of New Entrants 5 Global Tissue Engineering Market, by Device material 5.1 Introduction 5.1.1 Biomimetic Materials Synthesis 5.1.2 Nano-Fibrous Materials 5.1.3 Composite Materials 5.1.4 Nano-Composite Materials Continue... Regional Analysis: Globally North America has the largest share in the tissue engineering market. North America holds about 47% market share for the global tissue engineering market. The share of this nation in this market is mainly due to increasing research and development in tissue engineering. Europe is the second-largest market for Tissue Engineering. Asia Pacific is expected to be fastest growing market for Tissue Engineering. Asia Pacific is expected to be the fastest growing market at a CAGR of 25.5% for the forecasted year from 2016 to 2022. About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our cooked research report (CRR), half-cooked research reports (HCRR), raw research reports (3R), continuous-feed research (CFR) and market research & consulting services. MRFR team have prime objective to provide top quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end-users and market players for global, regional and country level market segments enables our clients to know more consequently do more, which help them in answering all their most important questions. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meeting with industry experts and does industrial visits for its research analyst members. For more information, please visit https://www.marketresearchfuture.com/


— Orbis Research expect the Regenerative Medicine Market in the US to grow at a remarkable CAGR of more than 33% during the forecast period Regenerative medicine deals with the process of using therapeutically-induced or laboratory grown human tissue to treat diseased or injured human cells, tissues, or organs. It is an emerging field of treatment that helps in producing new cells to substitute malfunctioning or injured cells as a vehicle to treat disease and injury. The regenerative medicine market can be characterized into three major modalities, namely tissue engineering, biomaterials/ biomolecules, and stem cell therapy. Get a PDF Sample of Regenerative Medicine Market in the US Report at: http://www.orbisresearch.com/contacts/request-sample/201876 Regenerative Medicine Market in the US to grow at a fast pace, because of the growing demand for tissue-engineered and stem cell products for the treatment of various diseases. The potential of these medicines in regenerating diseased organs is one of the major factors that drives the market in the US. The stem cells application and advancements in nanotechnology will further drive the progress in this market. Segmentation by product and analysis of - cell therapy and scaffold Cell therapy helps in treating the diseases or to improving the functioning of the existing cells, by administrating of cells into the body. This therapy addresses medical conditions related to the bone, cartilage, heart, skin, digestive system, reproductive system, eye, blood, spine, brain, and the nervous system. In 2015, cell therapy segment accounted for approximately 80% of the market share. The report offers an analysis of each of the following segments and discusses its impact on the overall market growth - Cell therapy Scaffold Place a Purchase Order for this Report at: http://www.orbisresearch.com/contact/purchase/201876 Segmentation by application and analysis of - dermatology, musculoskeletal, ocular, and cardiovascular The year 2015 saw the precedence of the dermatology segment, accounting for a market share of more than 51%. Dermatology includes the treatment of burns and chronic wounds that requires a quick response, and skin grafting is essential in many cases. Factors such as the increase in obesity and diabetes, growing elderly population, and an increase in life expectancy are some of the causes contributing to the growth of the dermatology market. The report offers an analysis of each of the following segments and discusses its impact on the overall market growth - Dermatology Musculoskeletal Ocular Cardiovascular Regenerative medicine market in the US is highly competitive and fragmented because of the presence of several established vendors and this competitive environment is expected to intensify with advances in R&D and technological innovations. International players are likely to acquire regional or local players to enhance their products and expand their market share during the forecast period. The top vendors in the market are - Acelity Mesoblast Organogenesis Reprocell Stryker What will the market size and the growth rate be in 2020? What are the key factors driving the regenerative medicine market in the US? What are the key market trends impacting the growth of the regenerative medicine market in the US? What are the challenges to market growth? Who are the key vendors in the regenerative medicine market in the US? What are the market opportunities and threats faced by the vendors in the regenerative medicine market in the US? What are the key outcomes of the five forces analysis of the regenerative medicine market in the US? For more information, please visit http://www.orbisresearch.com/reports/index/regenerative-medicine-market-in-the-us-2016-2020


Sarasota, FL, Feb. 22, 2017 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Global Advanced Wound Care Management Market by Product type (advanced wound dressings (foam dressings, hydrocolloid dressings, Hydrofiber dressings, film dressings, alginate dressings, hydrogel dressings, collagen dressings), active wound care (artificial skin and skin substitutes, growth factors) and antimicrobial dressings) for Chronic and Acute wounds: Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 – 2022”. According to the report, global demand for the advanced wound care management market was valued at approximately USD 10.9 billion in 2016 and is expected to generate revenue of around USD 15.8 billion by end of 2022, growing at a CAGR of around 6.4% between 2017 and 2022. Browse through 29 Market Tables and 26 Figures spread through 110 Pages and in-depth TOC on “Global Advanced Wound Care Management Market: Type, Size, Share, Statistics, Trends, Analysis, Segment and Forecast 2016 – 2022”. The Wound Healing Society defines a chronic wound as a wound that fails to progress through a normal, orderly, and timely sequence of repair or passes through the repair process without restoring anatomic and functional results.  Standard wound care therapy is ineffective in treating chronic and complex wounds and additional treatment modalities need to be applied. Since chronic wounds are very painful and can lead to severe complications such as amputation and depression, advanced wound care management plays important role in treating chronic wounds. Global advanced wound care management market is primarily driven by increased incidences of chronic diseases such as diabetes across the world. Other major driving factors are a rise in aging population, advancement in technologies and rise in a number of surgical procedures. However, high treatment cost and reluctance to accept the newer therapies may limit the growth of the market. Increasing focus on the need for rapid healing along with wide arena of vast product range in wound care management is expected to act as an opportunity for advanced wound care management market in near future. Browse the full "Global Advanced Wound Care Management Market by Product type (advanced wound dressings (foam dressings, hydrocolloid dressings, Hydrofiber dressings, film dressings, alginate dressings, hydrogel dressings, collagen dressings), active wound care (artificial skin and skin substitutes, growth factors) and antimicrobial dressings) for Chronic and Acute wounds: Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022" report at https://www.zionmarketresearch.com/report/global-advanced-wound-care-management-market Advanced wound care management market is segmented into advanced wound dressings, active wound care and antimicrobial dressings based on product type. Advanced wound dressings are sub-segmented into foam dressings, hydrocolloid dressings, Hydrofiber dressings, film dressings, alginate dressings, hydrogel dressings, collagen dressings whereas active wound care is sub-segmented into the artificial skin and skin substitutes and growth factors. On the basis of the type of wound, the market is segmented as chronic wounds and acute wounds. Chronic wounds are further segmented into diabetic foot ulcers, pressure ulcer, venous leg ulcer and arterial ulcer whereas acute wounds as burns, surgical and traumatic wounds. Based on the end user, the market is segmented into hospitals, home healthcare and others (private nursing home, pharmacies). Inquire more about this report @ https://www.zionmarketresearch.com/inquiry/global-advanced-wound-care-management-market Advanced wound care segment contributed to largest share in 2015, however, active wound care segment will grow at fastest rate in the global market over the forecast period due to its effectiveness. Also, chronic wounds are more prevalent and will have the largest share in the market. North America represents developed regional markets for advanced wound care management and is expected to see the rapid growth in the years to come. The U.S. is by far the leading advanced wound care management market by country in North America. The U.S. market is expected to grow at the highest CAGR during the forecast period. This growth is mainly due to increase prevalence of chronic diseases such as diabetes, vascular diseases and the increase in aging population. Moreover, increasing expenditure in healthcare will also promote the growth of advanced wound care management market in this region. Europe was the second largest regional market and is expected to show significant growth in the years to come. This growth is mainly due to increase in the diabetic patient pool and geriatric population. Asia-Pacific is expected to witness noticeable growth in the near future. In Asia, China, India, and Japan will continue to be the fastest growing markets in advanced wound care management market. This growth in Asia Pacific market is attributed to the surge in the diabetic patient pool and large geriatric population base in countries like India and China. In Middle East & Africa; African region is projected to register low growth rate due the high cost of advanced wound care management. Latin America is another important regional market and is expected to experience moderate growth over the forecast period. Thus, all the aforementioned parameters are expected to propel the market growth in this region. Some of the key players in cancer drugs market include  Some of the key players in advanced wound care management market are 3M, Smith & Nephew plc., Acelity L.P. Inc., ConvaTec Inc., Medline Industries, Inc., Medtronic, Coloplast A/S, Organogenesis Inc. and Molnlycke Health Care. For more inquiry contact our sales team @ sales@zionmarketresearch.com This report segments the global advanced wound care management product market as follows: Global Advanced Wound Care Management Market: By Product Type Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Loading Organogenesis Inc collaborators
Loading Organogenesis Inc collaborators